{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:11Z","timestamp":1762868111721,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10552-020-01272-6","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T17:03:18Z","timestamp":1586192598000},"page":"525-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of two US breast cancer risk prediction models in German women"],"prefix":"10.1007","volume":"31","author":[{"given":"Anika","family":"H\u00fcsing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"Quante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Chang-Claude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krasimira","family":"Aleksandrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-2698","authenticated-orcid":false,"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356\u2013387","journal-title":"Eur J Cancer"},{"key":"1272_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"key":"1272_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1158\/1055-9965.EPI-18-0098","volume":"27","author":"RM Pfeiffer","year":"2018","unstructured":"Pfeiffer RM, Webb-Vargas Y, Wheeler W, Gail MH (2018) Proportion of U.S. trends in breast cancer incidence attributable to long-term changes in risk factor distributions. Cancer Epidemiol Biomark Prev 27:1214\u20131222","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1272_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"M Gail","year":"1989","unstructured":"Gail M, Brinton L, Byar D et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879\u20131886","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","volume":"91","author":"JP Costantino","year":"1999","unstructured":"Costantino JP, Gail MH, Pee D et al (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541\u20131548","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/jnci\/djm223","volume":"99","author":"MH Gail","year":"2007","unstructured":"Gail MH, Costantino JP, Pee D et al (2007) Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 99:1782\u20131792","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA et al (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358\u2013366","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-013-2428-y","volume":"138","author":"R Pastor-Barriuso","year":"2013","unstructured":"Pastor-Barriuso R, Ascunce N, Ederra M et al (2013) Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study. Breast Cancer Res Treat 138:249\u2013259","journal-title":"Breast Cancer Res Treat"},{"key":"1272_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13058-018-1084-x","volume":"20","author":"C Nickson","year":"2018","unstructured":"Nickson C, Procopio P, Velentzis LS et al (2018) Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women. Breast Cancer Res 20:155","journal-title":"Breast Cancer Res"},{"key":"1272_CR10","doi-asserted-by":"publisher","first-page":"e1001492","DOI":"10.1371\/journal.pmed.1001492","volume":"10","author":"RM Pfeiffer","year":"2013","unstructured":"Pfeiffer RM, Park Y, Kreimer AR et al (2013) Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med 10:e1001492","journal-title":"PLoS Med"},{"key":"1272_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/jnci\/djr172","volume":"103","author":"E Petracci","year":"2011","unstructured":"Petracci E, Decarli A, Schairer C et al (2011) Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst 103:1037\u20131048","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jnci\/djp018","volume":"101","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Tice JA, Bauer S et al (2009) Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101:384\u2013398","journal-title":"J Natl Cancer Inst"},{"key":"1272_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.cej.0000130014.83901.53","volume":"13","author":"P Boyle","year":"2004","unstructured":"Boyle P, Mezzetti M, La Vecchia C, Franceschi S, Decarli A, Robertson C (2004) Contribution of three components to individual cancer risk predicting breast cancer risk in Italy. Eur J Cancer Prev 13:183\u2013191","journal-title":"Eur J Cancer Prev"},{"key":"1272_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","volume":"2","author":"P Maas","year":"2016","unstructured":"Maas P, Barrdahl M, Joshi AD et al (2016) Breast cancer risk from modifiable and nonmodifiable risk factors among white women in the united states. JAMA Oncol 2:1295\u20131302","journal-title":"JAMA Oncol"},{"key":"1272_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13058-018-1073-0","volume":"20","author":"K Li","year":"2018","unstructured":"Li K, Anderson G, Viallon V et al (2018) Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts. Breast Cancer Res 20:147","journal-title":"Breast Cancer Res"},{"key":"1272_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.canep.2010.11.003","volume":"35","author":"BB Barnes","year":"2011","unstructured":"Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J (2011) Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol 35:345\u2013352","journal-title":"Cancer Epidemiol"},{"key":"1272_CR17","volume-title":"Global cancer observatory: cancer today","author":"JEM Ferlay","year":"2018","unstructured":"Ferlay JEM, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2018) Global cancer observatory: cancer today, 2018th edn. International Agency for Research on Cancer, Lyon","edition":"2018"},{"key":"1272_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000012786","volume":"43","author":"H Boeing","year":"1999","unstructured":"Boeing H, Wahrendorf J, Becker N (1999) EPIC-Germany\u2014a source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:195\u2013204","journal-title":"Ann Nutr Metab"},{"key":"1272_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113\u20131124","journal-title":"Public Health Nutr"},{"key":"1272_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/1471-2458-12-730","volume":"12","author":"C Scheidt-Nave","year":"2012","unstructured":"Scheidt-Nave C, Kamtsiuris P, Gosswald A et al (2012) German health interview and examination survey for adults (DEGS)\u2014design, objectives and implementation of the first data collection wave. BMC Public Health 12:730","journal-title":"BMC Public Health"},{"key":"1272_CR21","unstructured":"(2017) Human Mortality Database. Berkeley, USA, and Germany: University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany)"},{"key":"1272_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","volume":"3","author":"LJ Esserman","year":"2017","unstructured":"Esserman LJ, Anton-Culver H, Borowsky A et al (2017) The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 3:34","journal-title":"NPJ Breast Cancer."},{"key":"1272_CR23","first-page":"85","volume":"27","author":"TE Raghunathan","year":"2010","unstructured":"Raghunathan TE, Lepkowski JM, Van Hoewykand J, Solenberger P (2010) A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 27:85\u201395","journal-title":"Surv Methodol"},{"key":"1272_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30:377\u2013399","journal-title":"Stat Med"},{"key":"1272_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow SP (2000) Applied logistic regression, 2nd edn. Wiley, New York","edition":"2"},{"key":"1272_CR26","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","volume":"27","author":"K Visvanathan","year":"2009","unstructured":"Visvanathan K, Chlebowski RT, Hurley P et al (2009) American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 27:3235\u20133258","journal-title":"J Clin Oncol"},{"key":"1272_CR27","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/bcr3186","volume":"14","author":"R Ritte","year":"2012","unstructured":"Ritte R, Lukanova A, Berrino F et al (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 14:R76","journal-title":"Breast Cancer Res"},{"key":"1272_CR28","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1158\/1078-0432.CCR-16-3011","volume":"23","author":"A Husing","year":"2017","unstructured":"Husing A, Fortner RT, Kuhn T et al (2017) Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: results from the EPIC cohort. Clin Cancer Res 23:4181\u20134189","journal-title":"Clin Cancer Res"},{"key":"1272_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/jmedgenet-2011-100716","volume":"49","author":"A Husing","year":"2012","unstructured":"Husing A, Canzian F, Beckmann L et al (2012) Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet 49:601\u2013608","journal-title":"J Med Genet"},{"key":"1272_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv036","author":"N Mavaddat","year":"2015","unstructured":"Mavaddat N, Pharoah PD, Michailidou K et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv036","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-020-01272-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T23:35:13Z","timestamp":1617665713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-020-01272-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1007\/s10552-020-01272-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants in the EPIC and DEGS studies provided written informed consent. The EPIC study was approved by ethics committees at both study centers (Potsdam: Ethics Committee of the Medical Association of the State of Brandenburg; Heidelberg: Ethics Committee of the Heidelberg University Hospital). The Ethics Committee of Charit\u00e9 Hospital Berlin approved of the DEGS-Study, and the federal commissioner for data protection held no objections.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}